More and more vehicles are propelled by electric motors. The energy for the traction motor is stored in a high-voltage battery. The traction battery packs are installed at various locations of a vehicle and their enclosures consist of metal or plastic materials with smooth or textured surfaces.

EMI-Schutzfolien bewahren elektronische Geräte vor Beschädigungen oder Funktionseinschränkungen durch elektromagnetische Wellen.

Avoidance of damage caused by electromagnetic waves is an increasingly important topic in the electronics industry due to the growing number of electronic components being installed in automobiles. This increases the complexity of ensuring electromagnetic compatibility (EMC).

Charge transfers are caused by electrostatic charging, i.e. the separation of or friction between two materials. However, energized components such as cables and wires, chassis or PCBs may also cause flashovers unless they’re adequately insulated. Components may be damaged, people put at risk or combustible substances ignited by spark formation in this case as well.

Just like during a thunderstorm, electrostatic discharges can also occur in industrial environments: Whenever the difference between the charges of two objects is big enough this will result in a sudden equalization of potential. This flashover may destroy electronic components. Electromagnetic fields created by changes in electric currents and voltages can damage components as well. Protection films and labels from Schreiner ProTech reduce this risk: they provide insulation and shielding or warn against voltages.

Today – February 9, 2019 – the Falsified Medicines Directive 2011/62/EU has come into effect. It requires pharmaceutical manufacturers to provide secondary packaging of prescription medicines with an individual serial number as a 2D code for identification, plus a tamper-evident feature proving that the packaging is intact. This requirement is intended to stop illegal trading of falsified medicines.

Falsified medicines are a lucrative business for criminals. According to the “Pharmaceutical Crime: A Growth Market” research report published by the German Federal Criminal Police Office (BKA) in October 2016, one kilogram of the counterfeit version of a well-known potency-enhancing drug sells for 90,000 euros on average, whereas the price of cocaine is estimated at “merely” 65,000 euros. The serialization of packaging, complemented by anti-counterfeiting labels, helps stop this illegal trade.

Incidents of medicine counterfeiting increasingly often make the headlines – particularly when customs authorities achieve a major coup. In September 2017, German customs confiscated 950 parcels with 68,000 falsified pills and vials at only three parcel centers within a single week. An anonymized survey revealed that one in eight physicians has at one time or another held a counterfeit in his/her hand, and even six in 500 pharmacists have. One in seven counterfeits comes from a pharmacy in another EU country.

Mid-October, some 500 tons of fake medicines were confiscated in international raids. They included ineffective potency-enhancing drugs, pain killers and dietary supplements as well as counterfeit cancer drugs. According to Interpol, 116 countries were involved in the operation and 850 suspects arrested. This again shows the importance of tamper-proof packaging. An EU Directive-compliant closure seal provides an effective solution.

Treatment by self-medication with autoinjectors: a growing trend. For patients, the ease and safety of handling are particularly important. For pharmaceutical manufacturers, the protection of patients against fake medicines and security of the supply chain are crucial. The EU FMD, besides serialization, requires tamper protection of secondary packaging, however without considering first-opening indication for injection devices. That is exactly what the NFC-Label for autoinjectors is offering.

Often the less conspicuous a closure seal appears on medicinal packaging the more sophisticated the security technology it contains. Effects that are both conspicuous and unequivocal will only emerge when an informed expert authenticates the seal, like in the case of LumiSecure: Illumination by a special light makes colors on the label visible that can be clearly verified and thus indicate the authenticity of the packaged medicine.